Drawbacks of conventional parenteral drug delivery systems have paved the way for the development of improved techniques and better drug administration devices.

Over the past few years, there has been an evident shift towards the self-administration of drugs / therapies. These self-injection devices facilitate the effective administration of therapeutics for the treatment of emergency and chronic conditions.

The “Autoinjectors: IP Landscape” report features an extensive study of the key intellectual property (IP) documents (featuring granted autoinjectors patents, patent applications and other documents), describing the various types of autoinjectors and their components that offer safety features and patient compliance during self-administration of drugs. The insights generated in this report have been presented across two deliverables, a MS Excel workbook and a MS PowerPoint deck, summarizing the ongoing activity in this domain.

The research includes detailed profiles of 10+ key players (listed below); the profiles feature an overview of the developer, its financial information (if available), product portfolio (under development / marketed) recent developments and an informed future outlook.

• Bristol Myers Squibb
• Sanofi
• Ypsomed
• Novo Nordisk
• Owen Mumford
• Becton Dickinson
• Janssen
• SHL Group
• Amgen
• Aptar Pharma
• UCB
• Meridian Medical
• Eli Lilly
• PHC technologies
• Ascendis Pharma

Table of Contents

EXCEL DELIVERABLE

1. RESEARCH NOTES

2. SUMMARY DASHBOARD

3. OVERALL INTELLECTUAL PROPERTY LANDSCAPE DATASET

4. PRIOR ART SEARCH EXPRESSIONS (KEYWORD ANALYSIS)

5. PATENT APPLICATIONS DATASET

6. GRANTED PATENTS DATASET

7. CLAIMS ANALYSIS

8. KEY APPLICANTS ANALYSIS

9. CPC ANALYSIS

10. APPENDIX I: PIVOT TABLES

11. APPENDIX II: COUNTRY / GEOGRAPHY CODES

12. APPENDIX III: INNOVATION CATEGORIES

POWERPOINT DELIVERABLE

1. CONTEXT

2. PROJECT APPROACH

3. PROJECT OBJECTIVES

4. EXECUTIVE SUMMARY

5. INTRODUCTION

6. OVERALL INTELLECTUAL PROPERTY LANDSCAPE

7. KEY PRIOR ART SEARCH EXPRESSIONS

8. INTELLECTUAL PROPERTY VALUATION ANALYSIS

9. ANALYSIS OF PATENT APPLICATIONS

10. ANALYSIS OF GRANTED PATENTS

11. KEY APPLICANTS

12. POCKETS OF INNOVATION AND WHITE SPACES

13. FUTURE OUTLOOK

14. APPENDICES

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/autoinjectors-intellectual-property-landscape.html

You may also be interested in the following titles:

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com